July 26, 2022
One of Genuine Biotech's dugs has been approved by China to be used on patients with COVID-19. Azvudine is a pill originally formulated to treat patients with HIV and was approved for use last year.
The latest COVID Omicron subvariant BA.5 has been surging in cases throughout the world. While the vaccine does provide some protection, the virus is still able to evade the antibodies.
Private trials held by Genuine Biotech concluded that 40% of subjects experienced improvements in their symptoms after taking the drug. However, these findings do not align with federal trials concluding the percentage is closer to 10% and the drug provider will not release its results to the public. Nonetheless, China is prepared to begin production of almost 7 billion pills. Paxlovid, produced by Pfizer and having an efficacy rate of 89%, was also approved for use but is twice as expensive to make. Merck also has a treatment, Molnupiravir, that is 50% effective.
Comments